David M. Waterhouse, MD, MPH, reviews real-world claims data suggesting substantial underdiagnosis of Lambert-Eaton myasthenic syndrome among patients with small cell lung cancer and the need for improved recognition in oncology practice.
David M. Waterhouse, MD, MPH
Advertisement
Articles by David M. Waterhouse, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Full Approval to Afami-Cel for Advanced Synovial Sarcoma
2
Dose-Modified, Fixed-Duration Ibrutinib Plus Venetoclax Meets ORR End Point in Untreated CLL
3
Venetoclax/Ibrutinib Clears Resistance Mutations in BTK Inhibitor–Resistant CLL
4
Breaking Treatment Barriers: Therapy for Advanced (Metastatic) EGFR-Mutated Non-Small Cell Lung Cancer After Targeted Therapy and Chemotherapy
5